2022 International Congress Archives - Page 134 of 153

C-SURF: DBS programming using probabilistic maps as an efficient new approach to treat patients with dystonia: the results of a feasibility study.

F. Lange, M. Reich (Würzburg, Germany)
Can abdominal internal oblique muscle be a possible target for ultrasound-guided Botulinum toxin injection in patients with Parkinson’s Disease affected by axials problems? An ultrasound study of our case series.

F. Marenco, P. Arcuri, M. Meloni, M. Ramella, A. Castagna (Milan, Italy)
Can membrane association of α-synuclein aggregates lead to stress in the astrocytic endoplasmic reticulum?

A. Raj, I. Datta, R. Banerjee (Bangalore, India)
Can treatment of Helicobacter pylori decrease Parkinson’s disease risk?

L. Eisenberg, N. Giladi, V. Rozani, C. Peretz (Tel Aviv, Israel)
Can we add whey protein supplementation in patients with Parkinson’s disease without interfering with levodopa response?

G. Pinelli, C. Siri, A. Ranghetti, V. Cereda, R. Maestri, M. Canesi (Gravedona, Italy)
Cannabinoids for painful dystonia in corticobasal syndrome: a report of three patients

G. Rizzo, P. Avoni, V. Donadio, R. Liguori (Bologna, Italy)
Cannabis treatment in patients with Huntington’s disease in a clinic cohort was safe and effective

N. Omer, A. Bar David, N. Geva, Y. Zlotnik, T. Gurevich, S. Essa (Tel-Aviv, Israel)
Capturing the complexity of patients with parkinsonism: Baseline characteristics of participants in the PRIME-UK cross-sectional study

E. Tenison, D. Pendry-Brazier, M. Smith, F. Lithander, Y. Ben-Shlomo, E. Henderson (Bristol, United Kingdom)
Caregiver burden and quality of life in late stage Parkinson’s disease

K. Rosqvist, A. Schrag, P. Odin (Lund, Sweden)
Caregiver burden in Parkinson’s Disease patients with Cardiovascular Dysautonomia

C. Ledda, G. Imbalzano, C. Artusi, A. Merola, E. Montanaro, M. Zibetti, M. Rizzone, G. Sobrero, F. Vallelonga, S. Maule, L. Lopiano, A. Romagnolo (Turin, Italy)
Caregiver’s burden in Parkinson’s disease: A mixed methods study

AD. van Halteren, WM. Kapelle, CJ. Sederel, MJ. Meinders, M. Munneke, BRB. Bloem, SKL. Darweesh (Nijmegen, Netherlands)
CAREGIVERS BURDEN IN CARING FOR PERSONS WITH PARKINSON’S DISEASE: A SURVEY FROM A TEACHING HOSPITAL IN GHANA

M. Agoriwo, D. Markwei, E. Womorde (Ho, Ghana)
Caregiving patients with Parkinson disease treated with deep brain stimulation: a systematic review and meta-synthesis of qualitative research

V. Fioravanti, F. Cavallieri, F. Sireci, M. Parmeggiani, C. Pedroni, F. Mardones, M. Bassi, E. Moro, L. Ghirotto, F. Valzania (Reggio Emilia, Italy)
Case Report: Deep Brain Stimulation as a Potential Treatment for Stiff-Person Syndrome

E. Shah, S. Isfahani, D. Swope (Orange, USA)
Case report: Parkinsonim with dyskinesia secondary to amyloid angiopathy

K. Khelfaoui Tredano, G. Berrada, Y. Hsaini, A. Benomar, H. Tibar (Rabat, Morocco)
Case reports of first experiences worldwide with novel continuous oral levodopa dental pump in Parkinson’s Disease Patients

D. Mcintyre, O. Terwindt, L. Pavelka, G. Schilling, A. Znati, L. Skhiri, M. Gantenbein, E. Heller, A. Heller, J. Kennedy, J. Harmon, C. Kamp, M. Torti, CW. Olanow, R. Krueger (Strassen, Luxembourg)
Catatonic Syndrome in Covid-19 Infection: Medication Treatment or Hyperbaric Oxygen Therapy.

D. Labunskiy, S. Kiryukhina, V. Podsevatkin (Saransk, Russian Federation)
Categorizing non-focal dystonia, an un-biased data-driven approach

J. Younce, R. Cascella, J. Luna, S. Norris (St. Louis, USA)
CCDC88C p.R464H likely cause a novel late-onset parkinsonism phenotype

Z. Lin, W. Luo (Hangzhou, China)
CCL5 promotes Th17 migrating into SNpc by promoting Th17 proportion increase and LFA-1 expression

XZ. Xue (WuHan, China)
Central fatigue and glutamatergic overactivity in Parkinson’s disease: possible impact of safinamide

C. Pauletti, N. Locuratolo, D. Mannarelli, A. Maffucci, A. Petritis, F. Fattapposta (Rome, Italy)
Central olfactory structure atrophy is linked to synucleinopathy conversion in idiopathic REM sleep behavior disorder

KA. Woo, JY. Lee, H. Kim, YK. Kim (Seoul, Republic of Korea)
Central oscillation in the basal ganglia during re-emergent tremor pause in Parkinson’s Disease

M. Wilken, G. Bianchi, D. Andrés, M. Hallett, M. Merello (Buenos Aires, Argentina)
Cerebellar and other motor symptoms in Huntington’s Disease: A multiple scale correlation study

D. López-Mena, H. Martinez-Hernandez, J. Arista-Ramírez (Ciudad de Mexico, Mexico)
Cerebellar and other motor symptoms relationship with MRI features in Huntington disease.

H. Martinez-Hernandez, D. Lopez-Mena, A. Medina-Islas, L. Alvarez, I. Acosta (Mexico City, Mexico)
Cerebellar sodium disequilibrium in a patient with ATP1A3-related rapid onset dystonia-parkinsonism

J. Prasuhn, M. Göttlich, S. Großer, K. Reuther, B. Ebeling, A. Münchau, A. Nagel, N. Brüggemann (Lübeck, Germany)
Cerebellar transcranial direct current stimulation in spinocerebellar ataxia type 3: a randomized, double-blind, sham-controlled trial

R. Maas, S. Teerenstra, I. Toni, T. Klockgether, D. Schutter, B. Vande Warrenburg (Nijmegen, Netherlands)
CerebNet: Deep learning cerebellar subsegmentation for fast and reliable atrophy quantification

J. Faber, D. Kuegler, E. Bahrami, L. Heinz, D. Timmann, T. Ernst, K. Deike-Hofmann, B. Vande Warrenburg, G. Oz, J. van Gaalen, J. Joers, K. Reetz, T. Klockgether, M. Reuter (Bonn, Germany)
Cerebro-cerebellar motor networks in clinical subtypes of Parkinson’s disease

F. Agosta, S. Basaia, A. Francia, C. Cividini, R. Balestrino, T. Stojkovic, I. Stankovic, V. Markovic, E. Sarasso, A. Gardoni, R. de Micco, L. Albano, E. Stefanova, VS. Kostic, M. Filippi (Milan, Italy)
Cerebrospinal α-synuclein RT-QuIC in pathologically-confirmed Multiple System Atrophy

A. Symonds, G. Fairfoul, A. Green, D. Breen (Edinburgh, United Kingdom)
Cervical Dystonia After Resection of Posterior Fossa Meningioma

M. Vera, A. Grau, L. Lugo (Weston, USA)
Challenges and Opportunities People with Parkinson’s Disease Experienced Pre and Post-Covid-19 Vaccination

L. Currens, S. Carbone, J. Quast, W. Deeb (Worcester, USA)
Challenges in diagnosis of hereditary ataxia and spastic paraplegias

A. Planas-Ballvé, N. Caballol, X. Cardona, I. Gómez Ruiz, M. Balagué Marmaña, A. ávila (Barcelona, Spain)
Challenges in Outcome Measure Selection in Multi-Arm Multi-Stage Clinical Trials in Parkinson Disease

C. Gonzalez-Robles, M. Bartlett, M. Burnell, R. Chapman, R. Chaudhuri, C. Clarke, R. Ellis-Doyle, M. Hu, B. Huxford, A. Jha, M. Lawton, G. Mills, A. Noyce, P. Piccini, L. Rochester, J. Rudiger, C. Siu, D. van Wamelen, C. Williams-Gray, ML. Zeissler, H. Zetterberg, C. Carroll, T. Foltynie, R. Weil, A. Schrag (London, United Kingdom)
Challenging diagnosis of familial Gerstmann-Straussler-Scheinker disease with normal brain image: a case report and systematic review

KY. Park, SY. Jo, SJ. Chung (Seoul, Republic of Korea)
Changes in anticholinergic burden in patients with Parkinson’s disease (PD) after bilateral deep brain stimulation (DBS) of the globus pallidus (GP) and subthalamic nucleus (STN)

J. Jiao, M. Wilheimi, B. Brumbach, D. Safarpour (Portland, USA)
Changes in botulinum toxin dosing in cervical dystonia over 7 years

S. Rafee, M. Hutchinson (Dublin, Ireland)
Changes in gait and mobility measures collected in daily living conditions, in different stages of Parkinson’s disease

N. Geffen, K. Cohavi, N. Giladi, A. Thaler, R. Alcalay, J. Edgerton, J. Shirvan, J. Cedarbaum, J. Hausdorff, A. Mirelman (Tel Aviv, Israel)
Changes in the level of glial neurotrophic factor in Parkinson’s disease depending on the form

B. Muminov, R. Matmurodov, E. Abduqodirov (Tashkent, Uzbekistan)
Characterising Natural Killer cells in early Parkinson’s disease

J. Holbrook, B. Patel, M. Camacho, C. Williams-Gray (Cambridge, United Kingdom)
Characteristics and Techniques to Improve Micrographia in Parkinson’s Disease

S. Shahid (Southampton, USA)
Characteristics and Treatment Response to OnabotulinumtoxinA of Patients From CD-PROBE With Anterocollis Subtype of Cervical Dystonia

K. Dashtipour, J. Jankovic, D. Charles, S. Mehta, M. Schwartz, M. Sadeghi (Loma Linda, USA)
Characteristics and Treatment Response to OnabotulinumtoxinA of Patients From CD-PROBE With Retrocollis Subtype of Cervical Dystonia

K. Dashtipour, J. Jankovic, D. Charles, S. Mehta, M. Schwartz, M. Sadeghi (Loma Linda, USA)
Characteristics and validity of technologies analyzing voice features to assess symptoms – a review

J. Dean, V. Iankova Md, S. Schneider (Aurora, USA)
Characteristics of Fatigue and Correlation with the Symptoms of Parkinson’s Disease

XJ. Huang, Y. Qu, JT. Li, YP. Chen, JY. Li, QX. Qin, DL. Wang, JW. Zhao, ZJ. Mao, YJ. Xiong, Z. Min, Z. Xue (Wuhan, China)
Characterization of essential tremor patients in a central hospital-based sample.

A. Costa, C. Borges, C. Azoia, R. Jesus, R. Raimundo, AG. Velon (Vila Real, Portugal)
Characterization of gastrointestinal dysfunction in Parkinson’s by disease stage

M. Camacho, J. Greenland, D. Apostolopoulos, C. Daruwalla, C. Williams-Gray (Cambridge, United Kingdom)
Characterization of neuromelanin MRI as a potential Parkinson’s Disease biomarker in a multi-site longitudinal study

M. Ingalhalikar, H. Pham, L. Bracoud, RM. Hutchison, K. Evans, T. Dam, M. Sampat, J. Schaerer, C. Conklin, J. Suhy, D. Scott (San Mateo, USA)
Characterization of nociplastic pains in Parkinson’s disease (PD) with the PD pain classification system (PD-PCS)

V. Mylius, S. Lloret, N. Fisch, R. Gonzenbach, G. Kägi, J. Möller, F. Brugger, D. de Andrade (Valens, Switzerland)
Characterization of Perioperative Seizures in Patients Undergoing Deep Brain Stimulation for Movement Disorders: A Single-Center Study

G. Tamula, M. Moya-Mendez, C. O'Donovan, J. Tate, A. Laxton, S. Tatter, M. Siddiqui (WINSTON SALEM, USA)
Characterization of routine botulinum toxin (BoNT) therapy and patient population in cervical dystonia

B. Waeschle, H. Stark, P. Albrecht (Düsseldorf, Germany)
Chewing camel in stump

S. Dubey, P. Naveen (Bhopal, India)
Chikungunya: An emerging arthropod borne disease presenting as rhombencephalitis with near complete recovery

M. Shah, P. Shah, T. Singhal, K. Shetty, R. Syed, A. Aggarwal (Mumbai, India)
Childhood Trauma and Parkinson’s Disease: Associations of Adverse Childhood Experiences, Disease Severity and Quality of Life

I. Subramanian, B. Mcdaniels, J. Farahnik, L. Mischley (Los Angeles, USA)
Choice of shoulder muscles for the multi-pattern treatment of upper limb spasticity with botulinum neurotoxin injections

J. Jacinto (Alcabideche, Portugal)
Cholinergic Innervation and Cognitive Functioning in De Novo Parkinson’s Patients with GBA Variations

S. Slingerland, S. Vander Zee, JM. Boertien, AC. Slomp, T. van Laar (Groningen, Netherlands)
Cholinergic Nucleus 4 Degeneration and Cognitive Impairment in REM Sleep Behavior Disorder

C. Tan, H. Nawaz, S. Lageman, B. Berman, N. Mukhopadhyay, M. Barrett (Richmond, USA)
Chorea Hyperglycemic Basal Ganglia syndrome(CHBG) with Diabetic Lumbosacral Radiculoplexus Neuropathy – A rare case presentation

S. Pandey, M. Varma, C. Gaba, S. Jain, A. Goswami (New Delhi, India)
Chorea Severity Change Over Time in Huntington Disease and by Huntington Disease Stage

E. Furr Stimming, V. Sung, S. Reshef, R. Willock, R. Ribalov, S. Brighton, S. Leo (Houston, USA)
Chronic administration of bitopertin, a GlyT1 inhibitor, in the dyskinetic 6-OHDA-lesioned rat model of Parkinson’s disease

I. Frouni, W. Kang, D. Bédard, L. Desbiens, C. Kwan, A. Hamadjida, P. Huot (Montreal, Canada)
Chronic Visceral Pain in Parkinson’s Disease and Link with White Matter Hyperintensities

K. Rukavina, J. Staunton, M. Krbot Skoric, S. Rota, A. Rizos, K. Ray Chaudhuri (London, United Kingdom)
Chronotype and Cognition in Veterans with Parkinson’s Disease

A. Sarwar (Houston, USA)
Circadian cycle and disease phenotype in Parkinson’s disease, insights by motion sensors and molecular biology.

M. Marano, A. Casamassa, M. Rossi, A. Magliozzi, Z. Yekutieli, A. Vescovi, J. Rosati, V. Di Lazzaro (Rome, Italy)
Classical Machine Learning approaches to automate tremor detection from electrophysiological data

A. Vishnoi, R. Anandapadmanabhan, D. Biswas, A. Srivastava, D. Joshi, A. Mahabal (New Delhi, India)
Classification of extremity movements by visual observation of signal transforms

J. Brasic, L. Ziegelman, T. Kosuri, H. Hakim, L. Zhao, A. Gokce, K. Mathur, M. Hernandez, K. Mills (Baltimore, USA)
Classifying pain in dystonia: a way to improve pain outcome measure in dystonia.

C. Listik, E. Listik, G. Santos, F. Vale, F. Rolim, D. Portela, N. Araújo, P. Carvalho, S. Camargos, J. Lapa, R. Otani, R. Costa, E. Barbosa, R. Cury, J. Limongi, F. Cardoso, H. Ferraz, D. Andrade (Sao Paulo, Brazil)
Climb up! Head up! Climbing improves posture in Parkinson’s disease. A randomised controlled trial.

A. Langer, D. Roth, A. Santer, A. Flotz, J. Gruber, L. Wizany, S. Hasenauer, R. Pokan, P. Dabnichki, M. Treven, S. Zimmel, M. Schmoeger, U. Willinger, L. Gassner, W. Maetzler, H. Zach (Vienna, Austria)
Clinical and biomarker characteristics of Huntington’s Disease patients recently proposed for huntingtin-lowering clinical trial inclusion

G. Parkin, E. Thomas, C. Snell, A. Smirnova, A. Hall, L. Bohall, E. Churchill, J. Corey-Bloom (Irvine, USA)
Clinical and device-based predictors of improvement in motor experiences of daily living after a short-term multidisciplinary inpatient treatment: a cohort study

R. Scherbaum, J. Oppermann, A. Moewius, V. Tschentscher, J. Geritz, J. Welzel, C. Hansen, R. Gold, W. Maetzler, L. Tönges (Bochum, Germany)
Clinical and electrophysiological validation of a volume of tissue activation model for directional deep brain stimulation leads – the ReCaps study

P. Capetian, F. Lange, T. Binder, G. Brandt, R. Peach, J. Volkmann, D. Zeller (Wuerzburg, Germany)
CLINICAL AND GENEOLOGICAL FEATURES OF PARKINSON’S DISEASE

S. Kuranbaeva, S. Kalandarova, A. Umarov, G. Goyibova (Tashkent, Uzbekistan)
Clinical and genetic characterization of two Portuguese families with spinocerebellar ataxia 48

MJ. Lima, AR. Silva, P. Bem, C. Cruto, S. França, M. Rodrigues, A. Rua, M. Reis, J. Freixo, J. Oliveira, P. Salgado, M. Calejo (Senhora da Hora, Portugal)
Clinical and genetic research in a large Ukrainian family with autosomal recessive hereditary spastic paraplegia

A. Orlacchio, M. Stasi, A. Stigliano, M. Miele, F. Gaudiello, A. Meyyazhagan (Rome, Italy)
Clinical and Genetic spectrum of a series of congenital ataxias patients.

R. Baviera-Muñoz, L. Carretero-Vilarroig, M. Campins-Romeu, C. Morata, I. Sastre-Bataller, N. Muelas, I. Martínez-Torres, M. Tomás-Vila, T. Jaijo, E. Aller, L. Bataller (Valencia, Spain)
Clinical and Imaging features of Hyperkinetic Movement Disorders related with Stroke

H. Valdez Ruvalcaba, H. Martinez, G. Chac Lezama, F. de Leon, H. Pacheco Mendoza, V. Cano Nigenda, L. Alvarez, A. Arauz, A. Medina-Islas (mexico, Mexico)
Clinical and risk profiles of Parkinson’s disease from a large pan-India cohort: interim observations of the GAP-India study

A. Kishore, R. Borgohain, R. Rajan, K. Divya, L. Prashanth, P. Pal, S. Mehta, H. Kumar, N. Kumar, S. Desai, R. Kamdadai, S. Krishnan, M. Chacko, M. Sharma (Kochi, India)
Clinical characteristics in de-novo PD patients with reversible vs. progressive cognitive dysfunction during long-term follow-up

K. Kawabata, A. Djamshidian-Tehrani, K. Seppi, W. Poewe (Innsbruck, Austria)
Clinical Characteristics of patients with Parkinson’s disease showing normal values on SBR in the DAT SPECT

M. Nomoto, C. Ochi, R. Ando, Y. Murakami (Imabari, Ehime, Japan)
CLINICAL CHARACTERSITICS OF ESSENTIAL TREMOR PATIENTS THAT DEVELOPE PARKINSON´S DISEASE: A COHORT BASED STUDY.

C. Borrue- Fernandez (San Sebastian Reyes, Spain)
CLINICAL CORRELATION OF VISUAL LEUKOARAIOSIS SCALES AND VOLUMETRIC ANALYSIS IN PATIENTS WITH ISCHEMIC CEREBRAL VASCULAR EVENT AND PARKINSON’S DISEASE.

C. Cerda-Contreras (Monterrey, N.L., Mexico)
Clinical effectiveness and economic impact of transcutaneous afferent patterned stimulation therapy for essential tremor in a real-world setting: protocol for a pragmatic trial

D. Dai, J. Fernandes, LA. Ramel, H. Coetzer, V. Zraick, A. Samiian, L. Hennum (Woonsocket, USA)
Clinical Manifestations of Autonomic Dysfunction in Parkinsonism Assessed by COMPASS-31 Questionnaire

D. Tunjungsari, A. Tiksnadi (Jakarta, Indonesia)
Clinical Manifestations of Metabolic Syndrome in Parkinson’s Disease – Report from Indonesia Tertiary Referral Hospital

DA. Soraya, D. Tunjungsari, A. Tiksnadi (Jakarta, Indonesia)
Clinical Manifestations Of Mn-Induced Parkinsonism In The Workers Of Manganese Ferroalloy Ore

O. Koniashvili, G. Muzashvili, G. Khachiashvili, D. Daraselia, L. Gabunia (Tbilisi, Georgia)
Clinical Outcomes and Disease Burden of Advanced Parkinson’s Disease Patients Treated with Oral Medication Vs. Device-Aided Therapies: Preliminary Results from the University of Florida Registry Analysis

W. Hu, O. Ladhani, P. Kukreja, A. Ramirez-Zamora (Gainesville, USA)
Clinical phenotype of non-manifesting carriers of mutations in the GBA and LRRK2 genes

N. Omer, N. Giladi, A. Bar-Shira, M. Gana-Weisz, O. Goldstein, O. Asias, J. Shirvan, J. Cedarbaum, M. Kestenbaum, A. Orr-Urtreger, R. Alcalay, A. Mirelman, A. Thaler (Tel-Aviv, Israel)
Clinical presentation of SNCA Duplication Parkinsonism in a Family Kindred

K. Dent, M. Rochman, D. Kremens, J. Ratliff (Philadelphia, USA)
Clinical, environmental, and Technology-based gait measures in PD patients from a rural area in southwestern Colombia: a case-control pilot study

B. Muñoz-Ospina, H. Clavijo-Moran, D. álvarez-García, A. Navarro Cadavid, I. F Mata, J. Orozco Velez (Cali, Colombia)
Clinical, imaging and genetic characteristics from an Indian ARSACS cohort

A. Cherian, K P. Divya, B. Thomas (Thiruvananthapuram, India)
Clinical, imaging and genetic profile of patients with NBIA spectrum disorders

N. Sriram, P. Pal, V. Holla, N. Kamble, J. Saini, R. Yadav, RAJ. Battu, VY. K N, B. Muthusamy, RI. Kumari (Bangalore, India)
Clinical,imaging and genetic correlations in a Neuronal Brain Iron accumulation cohort from India

K P. Divya, A. Cherian, M. Chandarana, S. Krishnan (Thiruvananthapuram, India)
Clinically interpretable severity estimation of facial expression impairment in Parkinson’s disease

Y. Dushin, G. Morinan, G. Sarapata, J. O'Keeffe (London, United Kingdom)
Clinicopathologic features of corticobasal syndrome associated with corticobasal degeneration, progressive supranuclear palsy, Alzheimer’s disease, and FTLD-TDP

S. Koga, A. Murakami, D. Dickson (Jacksonville, USA)
Clinicopathologic features of primary lateral sclerosis with TDP-43 presenting as atypical parkinsonism

A. Murakami, S. Koga, S. Fujioka, K. Bieniek, H. Sekiya, M. Nakamura, Y. Tsuboi, M. Murray, Z. Wszolek, D. Dickson (Jacksonville, USA)
Closing the gap: Increasing access to genetic testing and counseling for Hispanics through PD research

P. Delgado Hodges, R. Deleon, A. Naito, R. Cruz Vicioso, A. Viñuelas, F. Velez Lago, L. Forastieri, I. F Mata (Indianapolis, USA)
Clove mediated Rescue in Parkinson’s Disease involves modulation of p53 and Sestrin2 in SHSY5Y cell line model

N. Rai, S. Dey (Udaipur, India)
Co-contractions as a Biomarker for DBS Efficacy in Dystonia

S. Lagerweij, J. van Zijl, H. Eggink, M. Smit, M. van Egmond, J. Elting, J. van Dijk, D. Oterdoom, M. Tijssen (Groningen, Netherlands)
Coexistence of Parkinson’s Disease and Myasthenia Gravis: Disease Characteristics and Confusion

Z. Mao, Q. Nie, Z. Li, Z. Xue (Wuhan, China)
Cognition in Huntington’s Disease

A. Sethi, O. Kaczmarek, S. Baek, B. Bumstead, M. Buhse, M. Zarif, M. Gudesblatt (Patchogue, USA)
Cognition in parkinson disease: Tunisian clinical experience

F. Syrine, B. Nadia, H. Hela, F. Saloua, B. Mariem, FRE. Mohamed (tunis, Tunisia)
Cognitive and Functional Trajectories in Prediagnostic Parkinson’s Disease

M. Bock, E. Vittinghoff, A. Bahorik, Y. Leng, K. Yaffe (San Francisco, USA)
Cognitive and Motor aspects of a Brazilian population with Parkinson´s disease and Impulse Control Disorders and/or Related Behaviors – an observational study.

B. Veiga, C. da Silva, L. Barcelos, H. Ferraz, S. Silva, V. Borges (São Paulo, Brazil)
Cognitive and Psychiatric Correlates of Fear of Falling in Progressive Supranuclear Palsy and Multiple System Atrophy

V. Martinez-Villota, C. Terroba-Chambi Chambi, S. Castillo-Torres, M. Rossi, M. Merello (Buenos Aires, Argentina)
Cognitive behavioral therapy for anxiety in Parkinson’s disease induces functional brain changes

G. Carey, R. Lopes, A. Moonen, A. Mulders, J. de Jong, G. Kuchcinski, L. Defebvre, M. Kuijf, K. Dujardin, A. Leentjens (Lille, France)
Cognitive dysfunction in cervical dystonia

M. Diepman, S. Rafee, M. Hutchinson, R. Sommers, F. O'Keeffe (Dublin 4, Ireland)
Cognitive Function in Late-life and Parkinson’s Disease Neuropathology at Death

R. Abbott, G. Ross, H. Petrovitch, K. Masaki, J. Uyehara-Lock, C. Tanner (Ansan-si, Republic of Korea)
Cognitive performance and learning parameters predict response to working memory training in Parkinson’s disease

A. Ophey, J. Wenzel, R. Paul, K. Giehl, C. Eggers, P. Reker, T. van Eimeren, E. Kalbe, L. Kambeitz-Ilankovic (Cologne, Germany)
Cognitive performances and autonomic dysfunction in MSA patients

G. Lazzeri, A. Carandina, T. Di Fonzo, F. Arienti, E. Monfrini, I. Trezzi, G. Franco, E. Tobaldini, A. Di Fonzo (Milan, Italy)
Cognitive profiles at presentation and subsequent cognitive decline in PD-MCI.

S. Mirza, S. Duff-Canning, M. Masellis, C. Marras (Toronto, Canada)
Cognitive profiling in a cohort of Huntington’s disease (HD) patients

M. Garon, F. Pistonesi, L. Weis, V. Cianci, T. Gandolfi, E. Fiorenzato, C. Tedesco, M. Campagnolo, M. Carecchio, A. Antonini, R. Biundo (Padua, Italy)
Cognitive-motor tests markedly increase the diagnostic rate of “On-meds” freezing of gait in Parkinson’s disease during clinical visits

Z. Pei (Guangzhou, China)
Collective expert perspectives on the use of safinamide as adjunctive therapy for Parkinson’s disease in Japan: Online-based Delphi approach

A. Takeda, Y. Tsuboi, M. Nomoto, H. Mochizuki, N. Hattori (Miyagi, Japan)
Color vision deficits in Parkinson’s disease are linked to brain abnormalities in attentional, fronto-pariental and visual networks

M. Diez-Cirarda, A. Murueta-Goyena, A. Miscioscia, R. Del Pino, S. Teijeira, MA. Acera, O. Lucas-Jimenez, N. Ojeda, B. Tijero, JC. Gomez-Esteban, I. Gabilondo (Barakaldo, Spain)
Combined anti N-Methyl-D- Aspartate receptor (NMDAR) encephalitis with autoimmune thyroiditis (AT), with good clinical recovery.

M. Farghal, M. Abu Hashish (Ahmadi, Kuwait)
COMBINED CSF α-SYN RT-QuIC, CSF NFL AND MIDBRAIN-PONS PLANIMETRY IN DEGENERATIVE PARKINSONISMS: FROM BEDSIDE TO BENCH, AND BACK AGAIN

C. Painous, M. Soto, M. Pulido-Salgado, M. Fernández, A. Camara, V. Sánchez, N. Bargallo, N. Caballol, C. Pont-Sunyer, M. Buongiorno, N. Martin, M. Basora, M. Tio, D. Giraldo, A. Pérez-Soriano, I. Zaro, E. Muñoz, MJ. Marti, F. Valldeoriola, Y. Compta (Barcelona, Catalonia)
Combining intraoperative microelectrode recordings with postoperative transcranial B-mode sonography of the brainstem to estimate the anatomical position of the electrode for chronic subthalamic nucleus deep brain stimulation in Parkinson´s disease

R. Reese, T. Kriesen, M. Kersten, A. Storch, M. Löhle, U. Walter (Rostock, Germany)
Common mistakes in the MoCA test in patients with Parkinson’s Disease in Kyrgyzstan

A. Il'Yazova, C. Shambetova, E. Zhunusova (Bishkek, Kyrgyzstan)
Comorbid neuropathological features in multiple system atrophy

H. Sekiya, S. Koga, A. Murakami, D. Dickson (Jacksonville, USA)
Comorbidities in Huntington’s disease: An Enroll-HD analysis

J. Mills, J. Long, J. Vaidya, C. Sampaio, S. Sathe (Iowa City, USA)
Comparing duodenal levodopa infusion based on length of treatment in advanced Parkinson’s.

J. Alonso Maroto, E. Casas Peña, I. Muro García, M. Domínguez Gallego, E. Valiente Gordillo, L. López Manzanares, JA. Vivancos Mora (Madrid, Spain)
Comparison between clinical and kinematic assessment of bradykinesia

G. Paparella, A. de Biase, L. Angelini, A. Cannavacciuolo, D. Colella, A. Guerra, D. Alunni Fegatelli, A. Berardelli, M. Bologna (Pozzilli, Italy)
COMPARISON OF CERVICAL, OCULAR AND MASSETER VESTIBULAR EVOKED MYOGENIC POTENTIALS IN PARKINSON PATIENTS ACCORDING TO CLINICAL SUBGROUPS

G. Sahbaz, R. Inan, B. Barut (Istanbul, Turkey)
COMPARISON OF COMPLICATIONS OF POST-COVID-19 IN PATIENTS WITH PARKINSONISM SYNDROME OF DIFFERENT GENESIS

O. Tondiy (Kharkiv, Ukraine)
Comparison of different risk scores for Parkinson’s disease in a population-based 10-year study

K. Marini, K. Seppi, S. Kiechl, H. Stockner, P. Willeit, J. Willeit, A. Djamshidian-Tehrani, G. Rungger, W. Poewe, P. Mahlknecht (Innsbruck, Austria)
Comparison of Disease Progression in Patients with Brain-first versus Body-first Parkinson’s Disease

DW. Ryu, SW. Yoo, KS. Lee, SG. Ha, JS. Kim (Seoul, Republic of Korea)
Comparison of efficacy and safety of adjunct treatments to levodopa in patients with Parkinson’s disease and wearing-off: A network meta-analysis of randomized, double-blind trials

Y. Kogo, W. Sako, M. Koebisu, H. Yamakage, T. Ishida, N. Hattori (Tokyo, Japan)
Comparison of Voice, Speech, Swallowing and Drooling Problems in Parkinson’s Disease Patients with Healthy Individuals

M. Sapmaz Atalar, G. Genç, ş. Oğur (Istanbul, Turkey)
Complications in Patients with Progressive Supranuclear Palsy

I. Aiba, H. Takigawa, R. Hanajima, T. Shimohata, M. Morita, K. Hasegawa, H. Kowa, M. Kanazawa, T. Tokuda, AM. Tokumaru, K. Nakashima, T. Ikeuchi (Nagoya, Japan)
Compound heterozygous mutation of the Beta galactosidase 1 gene presenting with familial dystonia and spondylo-epiphyseal dysplasia

A. Elavarasi, A. Anand, A. Garg, K. Garg, M. Singh, M. Tripathi, D. Vibha, R. Singh (New Delhi, India)
Compound heterozygous PANK2 variants in two unrelated kindreds with atypical PKAN

A. Saini, R. Mewara, B. Verma, V. Scaria, B. Bk, A. Srivastava, R. Rajan (New Delhi, India)
Computer vision can detect changes in bradykinesia associated with dopaminergic state in Parkinson’s disease

JF. Martín-Rodríguez, S. Camba Fernandez, D. Rodriguez Gordo, S. Garcia-Ojeda, B. Benitez Zamora, L. Muñoz-Delgado, F. Carrillo, P. Mir (Sevilla, Spain)
Computerized assessment of handwriting in Parkinson’s disease and its relation to motor symptoms

L. Diaz-Feliz, P. Sanz-Cartagena, M. Faundez-Zanuy, JM. Arbelo, P. García-Ruiz (Madrid, Spain)
COMT polymorphism as a genetic factor in levodopa-induced dyskinesia development in Russian patients with Parkinson’s disease

G. Akhmadeeva, I. Khidiyatova, I. Gilyazova, S. Umutbaev, O. Kachemaeva, A. Baitimerov, R. Galimova, R. Magzhanov (Ufa, Russian Federation)
Concomitant Medication Use and Levodopa Equivalent Daily Dose Requirements After Foslevodopa/foscarbidopa Initiation

D. Santos Garcia, L. Bergmann, B. Bergmans, F. Bergquist, S. Criswell, V. Fung, J. Jia, P. Kukreja, N. Pavasia, W. Robieson, Z. Zhang, D. Standaert (A Coruña, Spain)
Connectivity matrices for differentiating voluntary stopping states and involuntary freezing states in Parkinson’s disease

D. Salgado, A. Pineda, C. Alves, R. Carra, F. Rodrigues, M. Souza, R. Cury (São Paulo, Brazil)
Connectivity of dopaminergic networks in the continuum of Dementia with Lewy Bodies

A. Pilotto, S. Caminiti, E. Premi, A. Galli, E. Ferrari, G. Bonzi, S. Gipponi, E. Cottini, B. Paghera, D. Perani, A. Padovani (brescia, Italy)
Conservative iron chelation for Neuroferritinopathy

F. Marchand, C. Moreau, G. Kuchcinski, V. Huin, L. Defebvre, D. Devos (LILLE, France)
Contemporary study of the difficulties of late diagnostics in patients with Huntington’s disease in Uzbekistan

G. Goyibova, S. Kuranbaeva, A. Umarov, S. Kalandarova (Tashkent, Uzbekistan)
Continuous circadian intracerebroventricular administration of anaerobically preserved dopamine greatly reduces severe L-dopa-related complications in Parkinson’s disease

C. Moreau, P. Odou, A. Demailly, G. Touzet, N. Reyns, N. Carta, C. Barthelemy, D. Lannoy, B. Palas, B. Gouges, JC. Devedjian, L. Defebvre, M. Fisichella, D. Devos (Lille, France)
Continuous Dopaminergic Stimulation (CDS), different infusion rates

L. Quirós Illán, L. Ruiz-Escribano Menchen, JP. Cabello, F. Villanueva, I. Martin, A. Garcia Maruenda, P. Nieto Palomares, RE. Ibañez, J. Vaamonde Gamo (Ciudad Real, Spain)
Continuous subcutaneous apomorphine infusion for the management of Parkinson’s disease at the end-of-life

M. Bereau, M. Giffard, AL. Clairet, M. Verin, M. Auffret (Besançon, France)
Continuous wavelet transforms to improve the accuracy of motor assessments of Parkinson’s disease

T. Kosuri, J. Brasic (Baltimore, USA)
Contribution of cognitive load to akinetic and trembling freezing of gait manifestations in patients with Parkinson’s disease

P. Ginis, N. D'Cruz, D. Zoetewei, T. Herman, M. Gilat, J. Hausdorff, A. Nieuwboer (Leuven, Belgium)
Contribution of external globus pallidus to motor deficits of Parkinson’s disease: optogenetic studies in murine model

S. Dibisceglie Caballero, A. Ces, F. Ambroggi, M. Amalric, A. Ouagazzal (Marseille, France)
Correlation between 3 Tesla Brain MRI Nigrosome-1 imaging and SPECT 123I-Ioflupane in parkinsonian disorders

A. López-Jiménez, J. álvarez-Linera, JF. Boan, I. Pareés, M. Kurtis (Madrid, Spain)
Correlation between clinical scales and gait in Parkinson’s disease

A. Bitiati, C. de Oliveira, R. Treza, S. Hondo, E. Angeles, C. Bernardo, L. de Oliveira, M. Carvalho, M. Golin, D. Coelho (Santo André, Brazil)
Correlation between cognitive impairment and neuropsychiatric symptoms in Mexican persons living with Parkinson’s disease.

GI. Cerda-Hernández, AJ. Hernández-Medrano, P. Bazán-Rodríguez, E. Reséndiz-Henríquez, E. Ichikawa-Escamilla, MA. Ruiz-Mafud, RA. Abundes-Corona, A. Cervantes-Arriaga, M. Rodríguez-Violante, R. Solís-Vivanco (Mexico City, Mexico)
Correlation between cognitive/emotional factors and postural control in patients with Parkinson’s disease

A. Bitiati, C. de Oliveira, C. de Souza, A. Batista, R. Marquesini, A. Moreira-Neto, C. Batista, L. Teixeira, A. Pardini, D. Coelho (Santo André, Brazil)
Correlation between H-ABC and thyroid hormones signaling in the process of adult neurogenesis

A. Lopez-Juarez, V. Hernandez, D. Carmona (Leon, Mexico)
CORRELATION BETWEEN OLFACTORY DYSFUNCTION AND INTENSITY OF TREMOR

D D. Pokhabov, V. Abramov, M. Sadovsky, D V. Pokhabov (Krasnoyarsk, Russian Federation)
Correlation of Voice parameters and Dysphagia Severity in Multiple System Atrophy

T. Hähnel, L. Berger, K. Schimming, A. Vogel, G. Ebersbach, B. Falkenburger, F. Gandor (Dresden, Germany)
Correlations between cognitive impairments and brain abnormalities in Wilson disease: a systematic review

A. Hausmann, S. Kannenberg, C. Hartmann, J. Caspers, A. Schnitzler (Duesseldorf, Germany)
Cortical and cerebellar excitability in essential tremor

C. Ammann, C. Pagge, JA. Pineda-Pardo, M. Del álamo, R. Martínez-Fernández, A. Oliviero, JA. Obeso, G. Foffani (Móstoles, Spain)
Cortical beta activity in doorway-provoked motor blocks in Parkinson’s disease

S. Tran, J. Baarbe, R. Chen (Toronto, Canada)
Cortical Correlates of Gait in Pre-Manifest And Early Spinocerebellar Ataxia

V. Shah, D. Safarpour, F. Horak, C. Gomez, M. Mancini ()
Cortical oscillatory feature-based classification of Parkinson’s disease with freezing gait

A. Singh, S. Roy, KC. Santosh (Vermillion, USA)
Cortical responses evoked by stimulation of the subthalamic nucleus for intraoperative target determination in deep brain stimulation

M. Kersten, T. Kriesen, J. Heller, M. Löhle, A. Storch, R. Reese (Rostock, Germany)
Cortico-cortical connectivity is normalised by levodopa in tremor-dominant Parkinson’s disease

BK. Rurak, JP. Rodrigues, BD. Power, PD. Drummond, AM. Vallence (Murdoch, Australia)
Corticobasal syndrome and Parkinson’s disease at the beginning: usefulness of different asymmetrical patterns for early diagnosis.

G. Donzuso, G. Sciacca, A. Luca, C. Cicero, G. Mostile, A. Nicoletti, M. Zappia (Catania, Italy)
Covid vaccine induced parkinsonism and cognitive dysfunction

R. Dhamija, P. Talwar, S. Kushwaha, K. Gowdar (Delhi, India)
COVID-19 encephalitis with anti-mGluR1 antibody-positive cerebellar ataxia

F. Cheng, K. Tang, X. Wang (Kingston upon Hull, United Kingdom)
COVID-19 impact on Anxiety, Depression, Stress, and Cortisol in Persons with Parkinson’s Disease

B. Lobb, A. Hiller (Portland, USA)
COVID-19-associated antecollis: a case report

S. Kopishinskaia, I. Velichko, O. Ivanovskaia (Kirov, Russian Federation)
Critical appraisal of economic evaluation of biomarkers used for screening dementia

M. Azharuddin, M. Sharma (New Delhi, India)
Critical Bilateral Carotid Disease presenting as Hemichorea

M. Ferro, M. Gil Veiga, I. Fragata, C. Marques Matos (Lisboa, Portugal)
Cross-cultural validation of the Cebuano version of a screening questionnaire for Parkinson’s Disease

D. Dakay, F. Tangcalagan, E. Villanueva Iii, J. Abejero, G. Saranza (Mandaue City, Philippines)
CSF biomarkers in neurodegenerative parkinsonism can distinguish between multiple system atrophy and 4-repeat tauopathies, but not between disease with Lewy bodies and multiple system atrophy

P. Kanovsky, K. Bucilova, M. Chudackova, D. Konickova, K. Pekarova, K. Sklenarova, M. Kaiserova, S. Kurcova, M. Nevrly, J. Zapletalova, M. Strnad, K. Mensikova (Olomouc, Czech Republic)
Curcumin prevented electrophysiological and behavioral alterations in a rotenone model of Parkinson’s disease

L. Darbinyan, L. Hambardzumyan, L. Manukyan, K. Simonyan, V. Sarkisian (Yerevan, Armenia)
Current Concepts in Physical Therapy and Rehabilitation Protocol for Camptocormia: An Unusual Case Report

S. Calisgan, E. Calisgan, M. Ceylan, Y-E. Aktas (Manchester, United Kingdom)
Cycling Deep Brain Stimulation for Parkinson’s Disease

C. França, A. Bertholo, A. Pelicheck, I. Paraguay, J. Reis, D. Barros, J. Yamamoto, A. Coelho, R. Otani, M. Reuter, R. Carra, T. Guimarães, M. Teixeira, E. Barbosa, R. Cury (São Paulo, Brazil)